Natural variability in the disease course of SSc-ILD: implications for treatment
Interstitial lung disease (ILD) affects approximately 50% of patients with systemic sclerosis (SSc) and is the leading cause of death in SSc. Our objective was to gain insight into the progression of SSc-associated ILD (SSc-ILD). Using data from longitudinal clinical trials and observational studies...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2021-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/30/159/200340.full |